PKC-delta signalling pathway is involved in H9c2 cells differentiation (Articolo in rivista)

Type
Label
  • PKC-delta signalling pathway is involved in H9c2 cells differentiation (Articolo in rivista) (literal)
Anno
  • 2010-01-01T00:00:00+01:00 (literal)
Alternative label
  • DI Giacomo V, Rapino M, Sancilio S, Patruno A, Zara S, Di Pietro R, Cataldi A. (2010)
    PKC-delta signalling pathway is involved in H9c2 cells differentiation
    in Differentiation (Lond.)
    (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#autori
  • DI Giacomo V, Rapino M, Sancilio S, Patruno A, Zara S, Di Pietro R, Cataldi A. (literal)
Pagina inizio
  • 204 (literal)
Pagina fine
  • 212 (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroVolume
  • 80 (literal)
Rivista
Note
  • ISI Web of Science (WOS) (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#affiliazioni
  • Dipartimento di Medicina e Scienze dell’Invecchiamento, Chieti, Italy; Cattedra di Anatomia Umana, Facoltà di Farmacia, Università G. d’Annunzio, Chieti-Pescara, Italy; Dipartimento di Scienze del Farmaco,Università G. d’Annunzio, Chieti-Pescara, Italy; Istituto di Genetica Molecolare del CNR, Unit à di Chieti, Italy (literal)
Titolo
  • PKC-delta signalling pathway is involved in H9c2 cells differentiation (literal)
Abstract
  • H9c2 are rat heart embryonic myoblasts, with skeletal muscle properties, which terminally differentiate by fusing and forming multinucleated myotubes. Here we investigated the possible involvement of Protein Kinases C (PKCs) in H9c2 cell differentiation and explored the interplay of these enzymes both with reactive oxygen species (ROS), upstream physiological mediators of cell differentiation, and with nitric oxide (NO), downstream target of PKC activation, known for being involved in apoptosis induction in differentiated myoblasts. Cells were induced to differentiate (6 days) under low serum culture conditions and assayed for the expression of cell cycle (cyclin A) and differentiation markers (morphology and myogenin). Both ROS and in vivo production of NO were found increased after 6 days of differentiation, when the activation of PKC-delta isoform was 14-fold increased compared with the undifferentiated control cells. The parallel analysis of apoptotic features demonstrated a small increase in Annexin-V+ cells and a concomitant increase in PARP cleavage and Bax expression. Interestingly, a reduced percentage of differentiated cells was obtained both in the presence of Rottlerin, a highly selective PKC-delta pharmacologic inhibitor, and, moreover, with the use of PKC-delta siRNA technology, further supporting the involvement of PKC-delta in switching on the events related to skeletal muscle myoblast differentiation. (literal)
Prodotto di
Autore CNR
Insieme di parole chiave

Incoming links:


Autore CNR di
Prodotto
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#rivistaDi
Insieme di parole chiave di
data.CNR.it